Autonomix Medical, Inc.
For the period ended Mar 31, 2026. Filed May 27, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed May 27, 2026
AMIX$1.85+8.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Balance Sheets as of March 31, 2026 and 2025
Balance Sheets
| (in thousands, except par value and share data) | As of | |
|---|---|---|
| March 31, | ||
| 2026 | 2025 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $7,004 | $9,136 |
| Other current assets | 577 | 473 |
| Total current assets | 7,581 | 9,609 |
| Noncurrent assets: | ||
| Property and equipment, net | 19 | 21 |
| Deferred offering costs | — | 176 |
| Total noncurrent assets | 19 | 197 |
| Total Assets | $7,600 | $9,806 |
| Liabilities and Stockholders' Equity | ||
| Current liabilities: | ||
| Accounts payable | $700 | $676 |
| Accrued expenses | 1,005 | 1,031 |
| Total current liabilities | 1,705 | 1,707 |
| Total Liabilities | 1,705 | 1,707 |
| Commitments and contingencies (Note 4) | ||
| Stockholders' equity: | ||
| Preferred stock, $0.001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of March 31, 2026 and 2025, respectively | — | — |
| Common stock, $0.001 par value, 500,000,000 shares authorized, 11,409,344 and 2,497,033 shares issued and outstanding as of March 31, 2026 and 2025, respectively | 11 | 2 |
| Additional paid-in capital | 72,978 | 58,476 |
| Accumulated deficit | (67,094) | (50,379) |
| Total Stockholders' Equity | 5,895 | 8,099 |
| Total Liabilities and Stockholders' Equity | $7,600 | $9,806 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.